gr 65630 has been researched along with 4-chloro-2-(2-imidazolin-2-ylamino)isoindoline in 1 studies
Studies (gr 65630) | Trials (gr 65630) | Recent Studies (post-2010) (gr 65630) | Studies (4-chloro-2-(2-imidazolin-2-ylamino)isoindoline) | Trials (4-chloro-2-(2-imidazolin-2-ylamino)isoindoline) | Recent Studies (post-2010) (4-chloro-2-(2-imidazolin-2-ylamino)isoindoline) |
---|---|---|---|---|---|
57 | 0 | 4 | 12 | 0 | 1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bönisch, H; Brüss, M; Göthert, M; Molderings, GJ | 1 |
1 other study(ies) available for gr 65630 and 4-chloro-2-(2-imidazolin-2-ylamino)isoindoline
Article | Year |
---|---|
Pharmacological differences and similarities between the native mouse 5-HT3 receptor in N1E-115 cells and a cloned short splice variant of the mouse 5-HT3 receptor expressed in HEK 293 cells.
Topics: Alternative Splicing; Animals; Binding, Competitive; Carbon Radioisotopes; Cell Line; Cloning, Molecular; DNA, Complementary; Dose-Response Relationship, Drug; Gene Expression; Genetic Variation; Guanidine; Humans; Hybrid Cells; Imidazoles; Indoles; Isoindoles; Membranes; Mice; Piperidines; Radioligand Assay; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Recombinant Fusion Proteins; Sequence Analysis, DNA; Serotonin; Serotonin Agents; Substance P; Transfection; Tritium; Tumor Cells, Cultured | 1999 |